🇺🇸 Sodium warfarin in United States

133 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 20 reports (15.04%)
  2. Dyspnoea — 16 reports (12.03%)
  3. Asthenia — 13 reports (9.77%)
  4. Atrial Fibrillation — 13 reports (9.77%)
  5. Fatigue — 13 reports (9.77%)
  6. Nausea — 13 reports (9.77%)
  7. Pneumonia — 12 reports (9.02%)
  8. Thrombosis — 12 reports (9.02%)
  9. Rash — 11 reports (8.27%)
  10. Dizziness — 10 reports (7.52%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Sodium warfarin approved in United States?

Sodium warfarin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Sodium warfarin in United States?

University of Padova is the originator. The local marketing authorisation holder may differ — check the official source linked above.